OQS
IRMD icon

Occudo Quantitative Strategies’s iRadimed IRMD Stock Holding History

Occudo Quantitative Strategies’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
5,154
+432
+9% +$39.3K 0.03% 509
2026
Q1 		$394K Buy
+4,722
New +$472K 0.02% 534
2025
Q2 		– Sell
-4,550
Closed -$238K – 767
2025
Q1 		$238K Buy
+4,550
New +$256K 0.03% 525
2024
Q1 		– Sell
-4,259
Closed -$202K – 890
2023
Q4 		$202K Buy
+4,259
New +$179K 0.03% 647
2023
Q3 		– Sell
-4,602
Closed -$220K – 1133
2023
Q2 		$220K Buy
+4,602
New +$208K 0.02% 824

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Occudo Quantitative Strategies's IRMD Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its iRadimed (IRMD) stake by 9.1% in Q2 2026, buying an estimated $39.3K and bringing the position to 5,154 shares worth $493K. The position accounts for 0.03% of the portfolio, ranked #509.

Occudo Quantitative Strategies first reported a position in IRMD in Q2 2023 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Occudo Quantitative Strategies held 5,154 shares of iRadimed worth $493K as of Q2 2026.
  • Occudo Quantitative Strategies bought 432 iRadimed shares in Q2 2026, an estimated $39.3K.
  • iRadimed made up 0.03% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #509 holding.
  • Occudo Quantitative Strategies first reported a position in iRadimed in Q2 2023 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.